Education
About Us
Working with TipRanks
Follow Us
Firebrick Pharma Limited (AU:FRE)
:FRE
RESEARCH TOOLSreports
FRE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.05 - AU$0.10
Previous CloseN/A
Volume87.61K
Average Volume (3M)90.83K
Market Cap
N/A
Enterprise ValueAU$13.92M
Total Cash (Recent Filing)AU$911.20K
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta-0.82
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding227,321,700
10 Day Avg. Volume85,152
30 Day Avg. Volume90,829
Financial Highlights & Ratios
PEG Ratio-0.53
Price to Book (P/B)8.89
Price to Sales (P/S)0.00
P/FCF Ratio-7.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Firebrick Pharma Limited News
PremiumCompany Announcements
Firebrick Pharma Issues New Unlisted Options
PremiumCompany Announcements
Firebrick Pharma Raises Capital Through Share Issuance
PremiumCompany Announcements
Firebrick Pharma Expands Market Presence with New ASX Quotation
PremiumCompany Announcements
Firebrick Pharma Closes Placement with $0.2 Million FundingPremiumCompany Announcements
Firebrick Pharma Initiates Trading Halt Pending Share Placement Announcement
PremiumCompany Announcements
Firebrick Pharma Highlights Global Need for Nasodine
PremiumCompany Announcements
Firebrick Pharma’s Nasodine Nasal Spray Phase 3 Trial Results Published
PremiumCompany Announcements
Firebrick Pharma Withdraws Proposed Share PlacementOptions Prices
Currently, No data available
---
Ownership Overview
27.99% Insiders
―
Mutual Funds
― Other Institutional Investors
72.01% Public Companies and
Individual Investors
FRE FAQ
What was Firebrick Pharma Limited’s price range in the past 12 months?
Firebrick Pharma Limited lowest share price was AU$0.04 and its highest was AU$0.10 in the past 12 months.
What is Firebrick Pharma Limited’s market cap?
Currently, no data Available
When is Firebrick Pharma Limited’s upcoming earnings report date?
Firebrick Pharma Limited’s upcoming earnings report date is Aug 28, 2025 which is in 39 days.
How were Firebrick Pharma Limited’s earnings last quarter?
Currently, no data Available
Is Firebrick Pharma Limited overvalued?
According to Wall Street analysts Firebrick Pharma Limited’s price is currently Overvalued.
Does Firebrick Pharma Limited pay dividends?
Firebrick Pharma Limited does not currently pay dividends.
What is Firebrick Pharma Limited’s EPS estimate?
Firebrick Pharma Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Firebrick Pharma Limited have?
Firebrick Pharma Limited has 227,321,700 shares outstanding.
What happened to Firebrick Pharma Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Firebrick Pharma Limited?
Currently, no hedge funds are holding shares in AU:FRE
Firebrick Pharma Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:FRE Sentiment 70%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
24.00%
12-Months-Change
Fundamentals
Return on Equity
-111.71%
Trailing 12-Months
Asset Growth
-5.66%
Trailing 12-Months
Company Description
Firebrick Pharma Limited
Firebrick Pharma Limited engages in the development and commercialization of nasal spray treatment for the common cold under the Nasodine name in Australia. The company was incorporated in 2012 and is based in Melbourne, Australia.
Technical Analysis
Hexima Ltd
―
Botanix Pharmaceuticals Limited
―
Recce Pharmaceuticals Ltd.
―
Arovella Therapeutics Limited
―
Inoviq Ltd
―